American Cannabis Company Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for AMMJ based on fundamentals, valuation multiples, and historical data.

$51.83+3.60%
Bullish

Price Target Summary

Bear Case
$49.03
-5.4% from current
Base Case
$22.29
-57.0% from current
Bull Case
$40.13
-22.6% from current

Technical Outlook

52-Week Range Analysis

$51.61$64.75
Current: $51.83
Support Level
$52.92
Resistance Level
$63.44
From 52W High
-20.0%
From 52W Low
+0.4%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
$1.14B
Year 2 Projected
$1.65B
Year 3 Projected
$2.21B

Based on +56.3% YoY growth, tapered 20% per year in outer projections.

Valuation vs Peers

Current P/S
6.83x
Sector Median P/S
2.5x
Assessment
Premium to sector

Cash Position

Cash on Hand
$253.2M
Total Debt
$60.0M
Cash Runway
12 mo

Key Metrics

Current Price$51.83
Market Cap$6.61B
P/S Ratio6.83x
Revenue (TTM)$727.3M
Revenue Growth (YoY)+56.3%
Gross Margin39.7%
Cash on Hand$253.2M
Total Debt$60.0M
52W High$64.75
52W Low$51.61

Signal Breakdown

Overall Signal: Bullish
  • Strong revenue growth above 10% YoY
  • Healthy gross margins above 40%
  • Cash exceeds total debt
  • Trading near 52-week highs
  • Elevated P/S ratio relative to sector

Risk Factors

  • Limited cash runway: approximately 12 months of cash remaining at current burn rate.

Analyst Summary

American Cannabis Company (AMMJ) is a Ancillary cannabis company with rapidly growing revenue and a market capitalization of $6.61B. Based on trailing revenue of $727.3M and a P/S ratio of 6.83x, the stock trades at a premium relative to the sector median of 2.5x. Our algorithmic base-case price target of $22.29 implies downside of 57.0% from current levels. The overall signal is bullish, supported by positive fundamental indicators. Investors should weigh the 1 identified risk factor before making any investment decision.

Frequently Asked Questions

What is the price target for AMMJ?+
Our algorithmic base-case price target for American Cannabis Company (AMMJ) is $22.29, with a bear case of $49.03 and a bull case of $40.13. These targets are derived from sector-average and premium P/S multiples applied to projected revenue.
Is AMMJ a buy right now?+
Based on our algorithmic analysis, AMMJ currently carries a bullish signal. Strong revenue growth above 10% YoY. Healthy gross margins above 40%. This is not a buy or sell recommendation — always do your own due diligence.
What is the revenue forecast for American Cannabis Company?+
Based on the current year-over-year growth rate of +56.3%, we project AMMJ revenue at $1.14B in Year 1, $1.65B in Year 2, and $2.21B in Year 3. Growth rates are tapered in outer years.
What are the risks of investing in AMMJ?+
Limited cash runway: approximately 12 months of cash remaining at current burn rate.
How does AMMJ valuation compare to the cannabis sector?+
AMMJ has a trailing P/S ratio of 6.83x compared to the cannabis sector median of 2.5x. The stock premium to sector.

Important Disclaimer

This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.

← Back to AMMJ OverviewAll Cannabis Stocks